Gilead Sciences

India Bans Exports of Antiviral Drug Remdesivir as COVID-19 Cases Surge

Gilead’s Remdesivir Gets US FDA Approval for Hospitalised COVID-19 Patients

COVID-19: Remdesivir Caught in Storm After Poor WHO Trial Results and EU Deal

Remdesivir Shows No Benefits Against COVID-19 in Large WHO Trial

Medicine Nobel for Hep C Should Force Us to Think About Patents, Patients, Profits

Now, Sun Pharma to Sell COVID-19 Drug Favipiravir in India

Preliminary Results Suggest Dexamethasone Could Cut COVID-19 Mortality